NTRK Fusion in Non-Small Cell Lung Cancer: Diagnosis, Therapy, and TRK Inhibitor Resistance

MLA

Fangfang Liu, et al. “NTRK Fusion in Non-Small Cell Lung Cancer: Diagnosis, Therapy, and TRK Inhibitor Resistance.” Frontiers in Oncology, vol. 12, Mar. 2022. EBSCOhost, https://doi.org/10.3389/fonc.2022.864666.

APA

Fangfang Liu, Yuxuan Wei, Huan Zhang, Jizong Jiang, Peng Zhang, & Qian Chu. (2022). NTRK Fusion in Non-Small Cell Lung Cancer: Diagnosis, Therapy, and TRK Inhibitor Resistance. Frontiers in Oncology, 12. https://doi.org/10.3389/fonc.2022.864666

Chicago

Fangfang Liu, Yuxuan Wei, Huan Zhang, Jizong Jiang, Peng Zhang, and Qian Chu. 2022. “NTRK Fusion in Non-Small Cell Lung Cancer: Diagnosis, Therapy, and TRK Inhibitor Resistance.” Frontiers in Oncology 12 (March). doi:10.3389/fonc.2022.864666.